Mark Shapiro

Partner

Mark Shapiro is a partner at Pharma Initiatives. For two decades he was driven growth and innovation programs in clinical research with a focus on complex and challenging clinical trials. Prior to joining Pharma Initiatives, Mr. Shapiro was SVP, Operations at a global CRO, where he oversaw critical care research activities for several products used in the ER and ICU, as well as products design for battlefield use and intra-operative management of thrombosis and hemostasis. These programs were conducted in patients who were unable to provide written informed consent and required navigation of complex global regulatory requirements. He was previously a management consultant in the Clinical Development and Medical Affairs consulting practice at Campbell Alliance, now part of Syneos Health Consulting. He also managed a clinical trials network coordinating center at Duke University supported the community outreach and notification activities for an EFIC study.